RX Note

JULY 5, 2025

Intravenous factor replacement therapy for the treatment or prevention of bleeding is the mainstay of treatment for haemophilia. Since the mid-1980s, plasma-derived concentrates have been manufactured with a variety of virus-inactivating techniques including dry heat, pasteurization and treatment with chemicals (e.g.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunization Immunity Dosage 52

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." He was joined by Laura, a patient who began tirzepatide treatment shortly after being diagnosed with T2D.

Diabetes 32

Diabetes HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 32

Pharmacy Times

JULY 8, 2025

Further research is needed on the clinical impact, treatment longevity, and cost implications of biosimilar use in pediatric IBD. 2 Tumor necrosis factor alpha inhibitors (anti-TNFs) have become both first- and second-line therapies for the treatment of pediatric patients with Crohn disease and ulcerative colitis. years (IQR: 8.3–16.2

Biosimilars 40

Biosimilars HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 40

Pharmacy Times

JULY 17, 2025

Understanding and addressing barriers to medication adherence are crucial for effective treatment of psychiatric disorders and improving patient outcomes. Medication adherence is important for the successful treatment of psychiatric or behavioral health diagnoses. Front Psychiatry. 2024;14:1339801. doi:10.3389/fpsyt.2023.1339801

HIV Treatment and Prevention Agents 26

HIV Treatment and Prevention Agents Pharmacy Technician Hospitals Compounding Pharmacies 26

Pharmaceutical Technology

JULY 2, 2025

Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. Go deeper with GlobalData Reports LOA and PTSR Model - BRII-732 in Human Immunodeficiency Virus (HIV).

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Packaging Communication Hospitals 52

Pharmacy Times

JULY 3, 2025

She emphasizes that treatment options are mostly supportive, making prevention through good hygiene and vaccination essential. As a result, RSV is often overlooked as a contributing agent to respiratory and especially cardiorespiratory disease.

HIV Treatment and Prevention Agents 32

HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies Hospitals 32

Express Pharma

JULY 1, 2025

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious challenges that threaten long-term control of the disease. Targeted investment is needed to expand pre-exposure prophylaxis (PrEP) access, normalise HIV testing, and support earlier diagnosis.”

HIV Treatment and Prevention Agents 82

HIV Treatment and Prevention Agents 82

Pharmacy Times

JULY 15, 2025

Upon sensing dsRNA, the cell effectively halts protein synthesis, thereby preventing the virus from manufacturing the essential proteins required for its own reproduction. This innovative approach allowed for the high-throughput screening of many compounds, specifically 370,830, to discover potential therapeutic agents. EuerkAlert!

Compounding 32

Compounding Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies 32

Pharmaceutical Technology

JUNE 11, 2025

The US Food and Drug Administration (FDA) has placed a clinical hold on several of Gilead’s trials evaluating two HIV treatment candidates, though the rest of the drugmaker’s diverse pipeline remains unaffected. Gilead is considered the leading big pharma in HIV treatments. Shares in Nasdaq-listed Gilead opened 0.3%

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Express Pharma

DECEMBER 14, 2023

Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body. It is indicated for the treatment of HIV-1 infection in adult patients. It is also indicated for the treatment of HIV-1 infection in pediatric patients 3 years of age and older.

HIV Treatment and Prevention Agents 105

HIV Treatment and Prevention Agents 105

RX Note

JUNE 21, 2023

Introduction HIV (Human immunodeficiency virus) is an enveloped, single-stranded RNA virus that was recognized as the causative agent of AIDS (acquired immune deficiency syndrome). If HIV is left untreated, the virus will cause progressive weakening of the immune system, a process which occurs at different rates in different people.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunization Immunity Hospitals 52

Quality Matters

FEBRUARY 6, 2025

As more monoclonal antibody (mAb) therapies are developed (1 in 3 new drugs are monoclonal antibodies1) and as patent exclusivity expires, these treatments are becoming more widely available. Antigens are usually structures on the outside of the disease-causing agent. Anything that triggers an immune response is called an antigen.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunization Immunity Biosimilars 52

RX Note

JULY 3, 2023

. ° Nil © Complete ABG Arterial blood gases abx Antibiotics ACE Angiotensin converting enzyme ACS Acute coronary syndrome ADHD Attention deficit hyperactivity disorder ADME Absorption, distribution, metabolism or excretion ADR Adverse drug reaction AEBA Acute exacerbation of bronchial asthma AF Atrial fibrillation AGE Acute gastroenteritis AIDS Acquired (..)

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Communication Diabetes Hospitals 40

ID Stewardship

JUNE 19, 2025

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. The piece advocates for therapeutic drug monitoring (TDM) in specific high-risk groups to personalize treatment.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 52

PharmaShots

APRIL 25, 2023

This drug is currently in multiple P-IIa clinical trials and is being evaluated in combination with other antiviral agents for cHBV. ARO-AAT and ARO-APOC3 are among the highest-phase products developing under Arrowhead’s pipeline for the treatment of liver diseases. R&D Expenditure: $85.1M R&D Expenditure: $437.9M

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunization 40

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

Putting Patients First Blog

NOVEMBER 12, 2024

Recognizing PrEP as a preventive service rather than as indicative of an active medical condition, as HHS proposes, could help address the current risk selection seen in the market. Clear guidance on the treatment of rebates within the ACF will help avoid distortions in pricing and prevent patients from bearing disproportionate costs.

Insurance Coverage and Processing 52

Insurance Coverage and Processing HIV Treatment and Prevention Agents Communication Hospitals 52

Pharmacy Friday Pearls

MARCH 4, 2022

18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Hospitals Packaging Immunization 40

The Thyroid Pharmacist

JULY 20, 2023

And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. Viruses that have been associated with anemia include Epstein-Barr Virus , hepatitis A and C, human herpes virus 6 (HHV-6), cytomegalovirus, parvovirus B19, and HIV. [45] However, when they added 1.5

Health and Personal Care Stores 98

Health and Personal Care Stores HIV Treatment and Prevention Agents Immunization Immunity 98

pharmaphorum

JANUARY 5, 2022

The next phase of the Covid-19 – from vaccines to treatments. New COVID-19 treatments will also be available in 2022, but they are not a panacea. Pfizer reported in early December that Paxlovid, now also approved in US, Europe and UK, retained 89% efficacy in preventing hospitalisation and death from an earlier readout.

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Vaccines 98

The Thyroid Pharmacist

JANUARY 20, 2023

Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” Would you like to know if adaptogenic herbs might be of benefit to you? This can also mean fewer nutrients are absorbed.

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Diabetes Immunization Immunity 98

RX Note

FEBRUARY 23, 2023

Soft Contact Lenses - A basic overview Red Eye - Discussion on few possible conditions Styes - Warm compresses are the mainstay of treatment Eye Floaters - It is not often treated, except in severe cases.

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

ID Stewardship

DECEMBER 11, 2024

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM BALANCE RCT : Among hospitalized patients with bloodstream infection, antibiotic treatment for 7 days was non-inferior to treatment for 14 days. We hope you find this list helpful, maybe it will even inspire a journal club or two!

HIV Treatment and Prevention Agents 145

HIV Treatment and Prevention Agents Labelling Hospitals Communication 145